Home

ResMed Inc. Common Stock (RMD)

270.27
+2.96 (1.11%)
NYSE · Last Trade: Sep 28th, 6:14 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Align Technology, ResMed, Insulet, Envista, and Dentsply Sirona Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs. 
Via StockStory · September 25, 2025
Which S&P500 stocks are gapping on Thursday?chartmill.com
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Via Chartmill · September 25, 2025
ResMed Inc. (NYSE:RMD) Offers a Reliable Dividend with Strong Financial Healthchartmill.com
Learn how ResMed (RMD) exemplifies a strong dividend stock with a 10+ year growth streak, a low payout ratio, and robust profitability for reliable passive income.
Via Chartmill · September 25, 2025
1 Cash-Producing Stock to Target This Week and 2 We Turn Down
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Via StockStory · September 23, 2025
ResMed Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)benzinga.com
Via Benzinga · September 18, 2025
This Progressive Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursdaybenzinga.com
Via Benzinga · September 18, 2025
This Target Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursdaybenzinga.com
Via Benzinga · September 18, 2025
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · September 17, 2025
Q2 Earnings Outperformers: ResMed (NYSE:RMD) And The Rest Of The Patient Monitoring Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at patient monitoring stocks, starting with ResMed (NYSE:RMD).
Via StockStory · September 11, 2025
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory · September 10, 2025
Top S&P500 movers in Wednesday's sessionchartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill · September 10, 2025
These S&P500 stocks are gapping in today's sessionchartmill.com
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · September 10, 2025
ResMed Inc. (NYSE:RMD): A Top Dividend Stock for Sustainable Income and Growthchartmill.com
ResMed (RMD) is a top dividend stock with a low payout ratio, strong financial health, and consistent growth, ensuring sustainable income for investors.
Via Chartmill · September 1, 2025
2 S&P 500 Stocks to Target This Week and 1 That Underwhelm
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Via StockStory · August 28, 2025
3 Reasons Investors Watch ResMed (RMD)
ResMed has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.9%. The stock now trades at $281.96, marking a 20.7% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Via StockStory · August 28, 2025
These S&P500 stocks are gapping in today's sessionchartmill.com
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Wednesday. Discover the gap up and gap down stocks in the S&P500 index.
Via Chartmill · August 27, 2025
1 Mooning Stock to Target This Week and 2 We Brush Off
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Via StockStory · August 26, 2025
RMD Q2 Deep Dive: Margin Expansion and Product Innovation Drive Outperformance
Medical device company ResMed (NYSE:RMD) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above analysts’ consensus estimates.
Via StockStory · August 12, 2025
ResMed Inc (NYSE:RMD): A Strong Dividend Stock with Growth Potential and Financial Stabilitychartmill.com
ResMed (RMD) offers a strong dividend with steady growth, backed by solid profitability and financial health, making it ideal for long-term income investors.
Via Chartmill · August 9, 2025
Discover the top S&P500 movers in Tuesday's pre-market session.chartmill.com
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Via Chartmill · August 5, 2025
ResMed RMD Q4 2025 Earnings Call Transcriptfool.com
Via The Motley Fool · August 4, 2025
Stay informed with the top movers within the S&P500 index on Monday.chartmill.com
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · August 4, 2025
The Analyst Verdict: ResMed In The Eyes Of 8 Expertsbenzinga.com
Via Benzinga · August 1, 2025
ResMed Analysts Increase Their Forecasts After Strong Q2 Earningsbenzinga.com
Via Benzinga · August 1, 2025
ResMed (RMD) Stock Is Up, What You Need To Know
Shares of medical device company ResMed (NYSE:RMD) jumped 3.1% in the afternoon session after the company reported strong fourth-quarter financial results that surpassed analyst estimates. 
Via StockStory · August 1, 2025